Vanguard Capital Wealth Advisors’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Vanguard Capital Wealth Advisors's PFE Position: Q4 2025 in Review
Vanguard Capital Wealth Advisors sold out of Pfizer (PFE) in Q4 2025, closing a stake of 10,925 shares — an estimated $278K sold.
Vanguard Capital Wealth Advisors first reported a position in PFE in Q4 2020 and held it in 18 quarters. The position peaked at $2.32M in Q4 2021. 2,905 funds tracked by Wall St. Rank hold PFE as of Q4 2025.
- Vanguard Capital Wealth Advisors reported no remaining Pfizer position as of Q4 2025 after selling out during the quarter.
- Vanguard Capital Wealth Advisors sold 10,925 Pfizer shares in Q4 2025, an estimated $278K.
- Vanguard Capital Wealth Advisors first reported a position in Pfizer in Q4 2020 and held it in 18 quarters.
- Vanguard Capital Wealth Advisors's Pfizer position peaked at $2.32M in Q4 2021.
- 2,905 funds tracked by Wall St. Rank held Pfizer as of Q4 2025.
Based on Vanguard Capital Wealth Advisors's 13F filing for Q4 2025, filed 16 Jan 2026.